Island company to make experimental lung cancer drug
A P.E.I. pharmaceutical company has signed a contract to make an experimental lung cancer drug for human clinical testing.BioVectra DCL will produce L-DOS47 for Helix BioPharma Corp. of Aurora, Ont. Helix specializes in developing cancer therapies
This entry was posted on Wednesday, January 31st, 2007 at 9:31 am and is filed under Research. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.